Pliant Therapeutics share price logo

Pliant Therapeutics

NASDAQ: PLRX

$1.12

-0.01

(-0.88%)

Live

as on

Pliant Therapeutics Stock Performance

as on September 19, 2026 at 5:11 am IST

  • Day's Low

    Day's High

    $1.10
    $1.13
    downward going graph

    1.79%

    Downside

    0.89%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.02
    $1.95
    downward going graph

    8.93%

    Downside

    74.11%

    Upside

    downward going graph

Pliant Therapeutics share price movements today

Previous Close
$1.13
Open
$1.13
Volume
535.9K
Market Cap
$69.4M
Day's Low - High
$1.10 - $1.13
52 Week Low - High
$1.02 - $1.95

Pliant Therapeutics Historical Returns

1 Month Return
-2.73 %
3 Month Return
-9.32 %
1 Year Return
-26.71 %
3 Year Return
-93.32 %
5 Year Return
-94.13 %

Pliant Therapeutics Stock Fundamentals & Key Indicators

Check Pliant Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$69.4M

EPS (TTM)

-1.49

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.75

Industry PE ratio

-2.36

PEG Ratio

-0.007742137781924203

EBITDA

-88.1M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-53.22%

Pliant Therapeutics Stock Valuation

Track how Pliant Therapeutics P/E has moved over time to understand its valuation trends.

Pliant Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-6.59x)

December 31, 2023

Industry (-2.36x)

December 31, 2025

Today (-0.50x)

December 31, 2025

Highest (-0.50x)

December 31, 2025

LowHigh

Today’s Price to Earnings Ratio: -0.50x

Pliant Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Pliant Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$69.4M-94.13%-0.750.00%0.00%
BUY$42.2B530.61%-22.230.00%0.00%
BUY$130.1B174.21%29.8186.04%0.00%
BUY$63.1B-63.24%-19.81-12.57%0.00%
BUY$79.7B21.1%18.4884.86%0.48%

Stock Returns calculator for Pliant Therapeutics Stock including INR - Dollar returns

The Pliant Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Pliant Therapeutics investment value today

Current value as on today

₹83,818

Returns

-₹16,182

(-16.18%)

Returns from Pliant Therapeutics Stock

-₹23,288 (-23.29%)

Dollar Impact

₹7,106 (+7.11%)

Analyst Recommendation on Pliant Therapeutics Stock

Based on 5 analysts

BUY

0.00%

Buy

80.00%

Hold

20.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Pliant Therapeutics. Average target price of $2

Pliant Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Pliant Therapeutics.

What analysts predicted

44%UPSIDE

Target Price

$2

Current Price

$1.12

Analyzed by

5 Analysts

Target

$2.00

Pliant Therapeutics target price $2, a slight upside of 44% compared to current price of $1.12. According to 5 analysts rating.

Indian Investors' Interest in Pliant Therapeutics Stock

Search interest for Pliant Therapeutics Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:7% versus previous 30 day period

Pliant Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
0
0
-
-
0
-
Operating Income
-52
-60
-62
-53
-58
-45
-28
-23
-21
-23
EBITDA
-45
-54
-56
-48
-54
-42
-23
-23
-19
-22
Interest Expense
0
0
0
0
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-46
-55
-57
-49
-56
-43
-26
-23
-20
-22
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-46
-55
-57
-49
-56
-43
-26
-23
-20
-22
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Pliant Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
57
41
7
9
1
-
-
Gross Profit
-
0
57
41
7
9
1
-
-1
Operating Income
-18
-30
-1
-41
-97
-127
-184
-228
-150
EBITDA
-18
-30
0
-40
-95
-118
-158
-205
-145
Interest Expense
-
-
0
0
-
0
1
3
2
Depreciation
0
0
1
1
1
3
1
2
1
Income Before Tax
-18
-30
0
-41
-97
-123
-161
-210
-149
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-20
-30
0
-41
-97
-123
-161
-210
-149
Net Profit Margin
0.00%
0.00%
100.00%
100.00%
100.00%
100.00%
100.00%
0.00%
0.00%

Pliant Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-46
-55
-57
-49
-56
-43
-26
-23
-20
-22
Operating Cash Flow
-30
-45
-32
-47
-48
-40
-21
-17
-19
-12
Investing Cash Flow
59
10
30
39
69
35
27
1
-4
15
Financing Cash Flow
21
0
0
0
0
-
0
-32
0
-
Change in Cash
51
-33
0
-8
20
-5
6
-48
-23
2

Pliant Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-18
-30
0
-41
-97
-123
-161
-210
-149
Operating Cash Flow
-16
-28
-2
-37
-75
-94
-116
-155
-128
Investing Cash Flow
-1
-2
-17
-210
73
-150
-127
140
134
Financing Cash Flow
20
87
45
213
2
226
274
23
-31
Change in Cash
1
56
24
-34
0
-17
31
7
-25

Mutual Funds that own Pliant Therapeutics Stock

Check out the Mutual Funds with significant holdings in Pliant Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.725304%
2306779
Bridgeway Funds, Inc.
0.894077%
553630
Fidelity Concord Street Trust
0.482439%
298736
TIAA-CREF Funds
0.200291%
124024
VANGUARD WORLD FUND
0.186268%
115341

Global Institutional Holdings in Pliant Therapeutics

Funds
Holdings
Vanguard
4.07%
Michael Rockefeller
2.09%
iShares
0.33%
Invesco
0.17%
Bridgeway
0.13%

Insights on Pliant Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 521.1% return, outperforming this stock by 545.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 51.8% return, outperforming this stock by 144.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, PLRX stock has moved down by -93.1%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -20.03M → -22.37M (in $), with an average decrease of 11.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 4.83M → 2.27M (in $), with an average decrease of 53.1% per quarter

About Pliant Therapeutics

Pliant Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing integrin-based therapeutics for the treatment of solid tumors. The company's lead product candidate is the PLN-101095, an oral, small molecule dual inhibitor of avß8 and avß1 integrins that is in Phase 1a/1b for the treatment of solid tumors. It is also developing drug discovery platform comprising proprietary library of over 15,000 integrin binding molecules, focusing on integrin-based target-mediated drug delivery. Pliant Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.
OrganisationPliant Therapeutics
Headquarters331 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
IndustryBiotechnology
CEODr. Bernard Coulie M.B.A., M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Pliant Therapeutics

Name

Title

Ms. Delphine Imbert Ph.D.

Chief Technical Officer

Ms. Lily Cheung

Chief Human Resources Officer

Dr. Tim Machajewski Ph.D.

Senior VP & Head of Research

Dr. Bernard Coulie M.B.A., M.D., Ph.D.

President, CEO & Director

Dr. Keith Lamont Cummings M.B.A., M.D.

Chief Financial Officer

Ms. Minnie Kuo

Chief Operating Officer

Mr. Christopher S. Keenan

Vice President of Investor Relations & Corporate Communications

Dr. Rik Derynck Ph.D.

Scientific Founder & Member of Scientific Advisory Board

Mr. Dean Sheppard M.D.

Scientific Founder & Member of Scientific Advisory Board

Mr. Hal Chapman M.D.

Scientific Founder & Member of Scientific Advisory Board

FAQs

What is Pliant Therapeutics share price today?

Pliant Therapeutics share price today is $1.12 as on . Pliant Therapeutics share today touched a day high of $1.13 and a low of $1.10.

What is the 52 week high and 52 week low for Pliant Therapeutics share?

Pliant Therapeutics share touched a 52 week high of $1.95 on and a 52 week low of $1.02 on . Pliant Therapeutics stock price today i.e. is trending at $1.12,which is 42.56% down from its 52 week high and 9.80% up from its 52 week low.

What is Pliant Therapeutics's market capitalisation today?

Pliant Therapeutics market capitalisation is $0.00T as on .

How to invest in Pliant Therapeutics Stock (PLRX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Pliant Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Pliant Therapeutics Shares that will get you 1.3393 shares as per Pliant Therapeutics share price of $1.12 per share as on September 18, 2026 at 11:41 pm IST.

What is the minimum amount required to buy Pliant Therapeutics Stock (PLRX) from India?

Indian investors can start investing in Pliant Therapeutics (PLRX) shares with as little as ₹95.8725 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.73 in Pliant Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Pliant Therapeutics share’s latest price of $1.12 as on September 18, 2026 at 11:41 pm IST, you will get 8.9286 shares of Pliant Therapeutics. Learn more about fractional shares .

What are the returns that Pliant Therapeutics has given to Indian investors in the last 5 years?

Pliant Therapeutics stock has given -94.13% share price returns and 29.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?